| T cell dysfunction in cancer immunity and immunotherapy A Xia, Y Zhang, J Xu, T Yin, XJ Lu Frontiers in immunology 10, 1719, 2019 | 307 | 2019 |
| TOX promotes the exhaustion of antitumor CD8+ T cells by preventing PD1 degradation in hepatocellular carcinoma X Wang, Q He, H Shen, A Xia, W Tian, W Yu, B Sun Journal of hepatology 71 (4), 731-741, 2019 | 229 | 2019 |
| Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities AL Xia, XC Wang, YJ Lu, XJ Lu, B Sun Oncotarget 8 (52), 90521, 2017 | 118 | 2017 |
| Exosomes derived from exhausted CD8+ T cells impaired the anticancer function of normal CD8+ T cells X Wang, H Shen, Q He, W Tian, A Xia, XJ Lu Journal of Medical Genetics 56 (1), 29-31, 2019 | 67 | 2019 |
| Applications and advances of CRISPR-Cas9 in cancer immunotherapy AL Xia, QF He, JC Wang, J Zhu, YQ Sha, B Sun, XJ Lu Journal of medical genetics 56 (1), 4-9, 2019 | 66 | 2019 |
| The cancer-testis lncRNA lnc-CTHCC promotes hepatocellular carcinogenesis by binding hnRNP K and activating YAP1 transcription A Xia, W Yuan, Q Wang, J Xu, Y Gu, L Zhang, C Chen, Z Wang, D Wu, ... Nature cancer 3 (2), 203-218, 2022 | 51 | 2022 |
| Comprehensive treatments for hepatocellular carcinoma with portal vein tumor thrombosis JC Wang, AL Xia, Y Xu, XJ Lu Journal of Cellular Physiology 234 (2), 1062-1070, 2019 | 49 | 2019 |
| Long noncoding RNA GMAN promotes hepatocellular carcinoma progression by interacting with eIF4B J Xu, Y Lu, Q Liu, A Xia, J Zhao, X Xu, Q Sun, F Qi, B Sun Cancer letters 473, 1-12, 2020 | 41 | 2020 |
| MicroRNA‐3178 ameliorates inflammation and gastric carcinogenesis promoted by Helicobacter pylori new toxin, Tip‐α, by targeting TRAF3 M Zou, F Wang, A Jiang, A Xia, S Kong, C Gong, M Zhu, X Zhou, J Zhu, ... Helicobacter 22 (2), e12348, 2017 | 31 | 2017 |
| APAF1‐Binding long noncoding RNA promotes tumor growth and multidrug resistance in gastric cancer by blocking apoptosome assembly Q Wang, C Chen, X Xu, C Shu, C Cao, Z Wang, Y Fu, L Xu, K Xu, J Xu, ... Advanced Science 9 (28), 2201889, 2022 | 29 | 2022 |
| Cancer immunotherapy: challenges and clinical applications AL Xia, Y Xu, XJ Lu Journal of Medical Genetics 56 (1), 1-3, 2019 | 27 | 2019 |
| Genomic and epigenomic perspectives of T-cell exhaustion in cancer AL Xia, JC Wang, K Yang, D Ji, ZM Huang, Y Xu Briefings in functional genomics 18 (2), 113-118, 2019 | 11 | 2019 |
| Prognostic and predictive role of a metabolic rate‐limiting enzyme signature in hepatocellular carcinoma Z Wang, Y Fu, A Xia, C Chen, J Qu, G Xu, X Zou, Q Wang, S Wang Cell proliferation 54 (10), e13117, 2021 | 10 | 2021 |
| The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination A Xia, Q Yue, M Zhu, J Xu, S Liu, Y Wu, Z Wang, Z Xu, H An, Q Wang, ... Cell death discovery 9 (1), 169, 2023 | 8 | 2023 |
| A pan-cancer analysis of the prognostic and immunological roles of matrix metalloprotease-1 (MMP1) in human tumors S Mao, A Xia, X Tao, D Ye, J Qu, M Sun, H Wei, G Li Frontiers in oncology 12, 1089550, 2023 | 3 | 2023 |
| Non-coding RNAs in radiotherapy resistance: Roles and therapeutic implications in gastrointestinal cancer K Xu, H Guo, A Xia, Z Wang, S Wang, Q Wang Biomedicine & Pharmacotherapy 161, 114485, 2023 | 2 | 2023 |
| TKT-PARP1 axis induces radioresistance by promoting DNA double-strand break repair in hepatocellular carcinoma L Geng, M Zhu, D Luo, H Chen, B Li, Y Lao, H An, Y Wu, Y Li, A Xia, Y Shi, ... Oncogene 43 (9), 682-692, 2024 | | 2024 |
| Protein profiles reveal MSH6/MSH2 as a potential biomarker for hepatocellular carcinoma with microvascular invasion S Hong, J Zhang, S Liu, Q Jin, J Li, A Xia, J Xu Hepatology Research 54 (2), 189-200, 2024 | | 2024 |
| Protein profiles reveal MSH6/MSH2 as a potential biomarker for hepatocellular carcinoma with microvascular invasion MSH6/MSH2 is an biomarker for HCC with HCC. S Hong, J Zhang, S Liu, Q Jin, J Li, A Xia, J Xu Hepatology Research: the Official Journal of the Japan Society of Hepatology, 2023 | | 2023 |
| Functional genomics in the era of cancer immunotherapy: challenges and clinical implications AL Xia, Y Xu, XJ Lu Briefings in Functional Genomics 18 (2), 83-85, 2019 | | 2019 |
